Identifying risk factors for COVID-19 transmission in communities and workplaces

Risk Factors for Community- and Workplace Transmission of COVID-19

Observational Oslo University Hospital · NCT04320732

This study is trying to find out what factors help spread COVID-19 in communities and workplaces by asking questions to people who have had the virus, healthcare workers, and healthy volunteers.

Quick facts

Study typeObservational
Enrollment250000 (estimated)
Ages18 Years and up
SexAll
SponsorOslo University Hospital Academic / other
Locations1 site (Oslo)
Trial IDNCT04320732 on ClinicalTrials.gov

What this trial studies

This observational study aims to identify real-life risk factors associated with COVID-19 transmission through an electronic questionnaire. Participants will include hospitalized and non-hospitalized COVID-19 patients, healthcare personnel, and healthy volunteers. The study will utilize a web-based platform for data collection and consent, ensuring compliance with GDPR regulations. By analyzing the collected data, the study seeks to inform targeted public health measures to mitigate the spread of the virus.

Who should consider this trial

Good fit: Ideal candidates for this study are Norwegian adults, including those diagnosed with COVID-19 and healthcare workers.

Not a fit: Patients who are unable to provide consent will not benefit from this study.

Why it matters

Potential benefit: If successful, this study could provide critical insights that help reduce COVID-19 transmission rates in communities and workplaces.

How similar studies have performed: Other studies have successfully identified risk factors for COVID-19 transmission, making this approach both relevant and necessary.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Norwegian adult

Exclusion Criteria:

* Unable to consent

Where this trial is running

Oslo

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Coronavirus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.